NLRP3 and Parkinson disease: In MES23.5 cells, ACP hindered the expression of ROS-NLRP3 induced by 6-OHDA, providing a protective effect, and decreased the activation of ROS-NLRP3 in the SN–striatum, thereby augmenting the exercise capacity of PD mice [145].